Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | CES1 | P23141 | 4/20 | 0.38 |
| ▸ | CES2 | O00748 | 3/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.37 |
| ▸ | NAPRT | Q6XQN6 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 3/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | ESR1 | P03372 | 2/20 | 0.35 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.35 |
| ▸ | CA12 | O43570 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | CA4 | P22748 | 1/20 | 0.35 |
| ▸ | CA7 | P43166 | 1/20 | 0.35 |
| ▸ | CA9 | Q16790 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6903087 | 0.81 | CYP3A4 (0.39) | ALDH1A1CES1CES2NAPRTMAPT | |
| SCHEMBL28794384 | 0.81 | CYP3A4 (0.39) | ALDH1A1CES1CES2LMNACYP3A4 | |
| SCHEMBL1009627 | 0.81 | AKR1B1 (0.42) | ALDH1A1CES1CES2NAPRTLMNA | |
| SCHEMBL27550664 | 0.79 | AKR1B1 (0.41) | ALDH1A1CES1CES2NAPRTLMNA | |
| SCHEMBL28768934 | 0.79 | AKR1B1 (0.41) | ALDH1A1CES1CES2NAPRTLMNA | |
| SCHEMBL9518462 | 0.79 | AKR1B1 (0.41) | ALDH1A1CES1CES2NAPRTLMNA | |
| Ammonia Solution, Strong SCHEMBL31339446 | 0.79 | AKR1B1 (0.41) | ALDH1A1CES1CES2NAPRTLMNA | |
| SCHEMBL10728992 | 0.78 | ALDH1A1 (0.50) | ALDH1A1CES1CES2HSD17B10NAPRT | |
| SCHEMBL28674793 | 0.78 | HSD11B1 (0.44) | ALDH1A1CES1CES2LMNAMAPT | |
| SCHEMBL27438691 | 0.77 | CYP3A4 (0.36) | ALDH1A1HSD17B10LMNAMAPTCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7320835-B2 | Phosphorescent material | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2008-01-22 | — | — | US | claimed |
| US-20050196637-A1 | Phosphorescent material | LG CHEM, LTD. (KR) | 2005-09-08 | — | — | US | claimed |
| JP-2005518081-A | — | — | 2005-06-16 | — | — | JP | claimed |
| EP-1472909-A1 | ELECTROLUMINESCENT IRIDIUM COMPOUNDS WITH PHOSPHINOALKOXIDES AND PHENYLPYRIDINES OR PHENYLPYRIMIDINES AND DEVICES MADE WITH SUCH COMPOUNDS | E.I. du Pont de Nemours and Company (US) | 2004-11-03 | — | — | EP | claimed |
| US-20030173896-A1 | Electroluminescent iridium compounds with phosphinoalkoxides and phenylpyridines or phenylpyrimidines and devices made with such compounds | LG CHEM, LTD. (KR) | 2003-09-18 | — | — | US | claimed |
| WO-2003069961-A1 | ELECTROLUMINESCENT IRIDIUM COMPOUNDS WITH PHOSPHINOALKOXIDES AND PHENYLPYRIDINES OR PHENYLPYRIMIDINES AND DEVICES MADE WITH SUCH COMPOUNDS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2003-08-21 | — | — | WO | claimed |
| WO-2024129836-A1 | BISCATIONIC QUATERNARY PHOSPHONIUM COMPOUNDS AS SOFT ANTIMICROBIAL AGENTS | VILLANOVA UNIVERSITY (US) | 2024-06-20 | — | — | WO | disclosed |
| CN-113474348-A | Substituted oxopyridine derivatives | 拜耳公司 | 2021-10-01 | — | — | CN | disclosed |
| US-8871916-B2 | Diaryl phosphine compounds | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2014-10-28 | — | — | US | disclosed |
| US-20130203974-A1 | Preparation of Diazo and Diazonium Compounds | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2013-08-08 | — | — | US | disclosed |
| US-8350014-B2 | Preparation of diazo and diazonium compounds | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2013-01-08 | — | — | US | disclosed |
| US-20100125132-A1 | PREPARATION OF DIAZO AND DIAZONIUM COMPOUNDS | WISCONSIN ALUMNI RESEARCH FOUNDATION | 2010-05-20 | — | — | US | disclosed |
| US-7320835-B2 | Phosphorescent material | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2008-01-22 | — | — | US | disclosed |
| CN-1059665-C | Process for the preparation of 5-formylvalerate | DSM NV (NL) | 2000-12-20 | — | — | CN | disclosed |
| EP-0975574-A1 | PROCESS TO PREPARE A PENTENOIC ACID DERIVATIVE | DSM N.V. (NL) | 2000-02-02 | — | — | EP | disclosed |
| WO-1998038151-A1 | PROCESS TO PREPARE A PENTENOIC ACID DERIVATIVE | DSM N.V. (NL) | 1998-09-03 | — | — | WO | disclosed |
| CN-1138319-A | Process for the preparation of an aldehyde | DSM NV (NL) | 1996-12-18 | — | — | CN | disclosed |
| CN-1109866-A | Process for the preparation of 5-formylvalerate | DSM NV (US) | 1995-10-11 | — | — | CN | disclosed |
| CN-1021815-C | Process for the preparation of diesters of adipic acid | SHELL INT RESEARCH (NL) | 1993-08-18 | — | — | CN | disclosed |
| CN-88101605-A | Process for preparing adipic diester | — | 1988-11-23 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100125132-A1 | PREPARATION OF DIAZO AND DIAZONIUM COMPOUNDS | TREH, TALDO1, LIPE | ALDH1A1 2593/4885CES1 1341/4885CES2 711/4885 |
| US-20130203974-A1 | Preparation of Diazo and Diazonium Compounds | TREH, TALDO1, LIPE | ALDH1A1 2593/4885CES1 1341/4885CES2 711/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.